SCHEMBL29625915

SCHEMBL29625915

Cc1cccc(-n2c(=O)[nH]c(=O)[nH]c2=O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
KDM4E B2RXH2 3/20 0.50
TDP1 Q9NUW8 1/20 0.50
HSP90AA1 P07900 1/20 0.50
MGLL Q99685 1/20 0.50
HSD17B10 Q99714 3/20 0.49
TSHR P16473 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
USP2 O75604 3/20 0.47
ALDH1A1 P00352 3/20 0.47
TP53 P04637 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
ALOX5 P09917 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
GAA P10253 2/20 0.45
MAPT P10636 2/20 0.45
HTT P42858 1/20 0.45
HPGD P15428 1/20 0.45
NOTUM Q6P988 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9799805 0.79 KDM4E (0.59) LMNAKDM4EMGLLL3MBTL1ALDH1A1
SCHEMBL8321111 0.79 CYP1A2 (0.65) KDM4EMGLLL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL16004434 0.78 HSP90AA1 (0.59) KDM4ETDP1HSP90AA1MGLLHSD17B10
SCHEMBL8319159 0.78 GAA (0.46) LMNAKDM4EHSP90AA1HSD17B10ALDH1A1
SCHEMBL10437115 0.76 ALDH1A1 (0.50) LMNAKDM4ETDP1MGLLALDH1A1
SCHEMBL2337291 0.76 GSK3A (0.67) LMNAKDM4EHSD17B10TSHRL3MBTL1
SCHEMBL14884371 0.75 HSP90AA1 (0.55) LMNAKDM4ETDP1HSP90AA1MGLL
SCHEMBL11711805 0.74 GSK3A (0.64) LMNAKDM4EHSD17B10TSHRL3MBTL1
SCHEMBL9402511 0.73 GSK3A (0.57) LMNATDP1HSP90AA1MGLLHSD17B10
SCHEMBL7170106 0.73 GAA (0.44) LMNAKDM4ETDP1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114423743-A Triazine derivatives for the treatment of diseases associated with neurotrophic factors 阿泽克制药公司 2022-04-29 CN disclosed